CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS-Reference-Cited by-同舟云学术

CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS

Published:2008-07-29 Issue:9 Volume:5 Page:557-561
ISSN:1743-4254
Container-title:Nature Clinical Practice Oncology
language:en
Short-container-title:Nat Rev Clin Oncol

Author:

Hodi F Stephen,Oble Darryl A,Drappatz Jan,Velazquez Elsa F,Ramaiya Nikhil,Ramakrishna Naren,Day Arthur L,Kruse Andrea,Rae Suzanne Mac,Hoos Axel,Mihm Martin

Publisher

Springer Science and Business Media LLC

Subject

Oncology,General Medicine

Link

http://www.nature.com/articles/ncponc1183.pdf

Reference17 articles.

1. Aoyama H et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295: 2483–2491

2. Kerman AJ et al. (2006) Checkpoint blockade in cancer immunotherapy. Adv Immunol 90: 297–339

3. Bafaloukos D and Gogas H (2004) The treatment of brain metastases in melanoma patients. Cancer Treat Rev 30: 515–520

4. Barth A et al. (1995) Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 181: 193–201

5. Sampson JH et al. (1998) Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88: 11–20

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant-derived Molecules as Potent Anti-skin Cancer Agents;Current Cancer Therapy Reviews;2024-05-29

2. Recent Advances in the Development of Non‐Invasive Imaging Probes for Cancer Immunotherapy;Angewandte Chemie International Edition;2023-10-26

3. Recent Advances in the Development of Non‐Invasive Imaging Probes for Cancer Immunotherapy;Angewandte Chemie;2023-10-26

4. Breaking the ‘don’t eat me’ signal: in silico design of CD47-directed peptides for cancer immunotherapy;Molecular Diversity;2023-09-28

5. Assessing Response to Therapy;Oncologic Imaging : a Multidisciplinary Approach;2023